Redcare Pharmacy Taps Amazon Veteran to Drive Next Growth Phase

Redcare Pharmacy is making a strategic leadership move by appointing an Amazon finance veteran as its new Chief Financial Officer. Hendrik Krampe, who spent eight years as Finance Director for Amazon Europe, will assume the CFO role effective December 1, bringing two decades of e-commerce financial management experience to the German online pharmacy.

Strategic Timing for Leadership Transition

Krampe’s appointment coincides with Redcare Pharmacy’s release of strong third-quarter results, positioning him to immediately contribute to the company’s expansion strategy. His background includes not only his Amazon tenure but also ten years at eBay, providing him with extensive expertise in scaling digital business operations.

Board Chairman Björn Söder emphasized the strategic importance of this hire: “Hendrik brings us an internationally experienced finance chief with deep understanding of digital business models.” This expertise arrives as Redcare faces the challenge of efficiently scaling its rapidly expanding electronic prescription business.

Electronic Prescriptions Drive Record Performance

The company’s third-quarter results demonstrated substantial growth, with revenue climbing 27% organically to reach €719 million. The standout performer was Germany’s electronic prescription segment, which skyrocketed 122% compared to the same period last year.

Market share metrics reveal impressive traction, expanding from 0.27% in the first quarter of 2024 to 0.94% by the third quarter of 2025. This growth follows regulatory changes that enabled electronic prescriptions, allowing Redcare to capture significant market presence. The division now generates annual revenues exceeding €520 million, with substantial additional potential remaining untapped.

Should investors sell immediately? Or is it worth buying Redcare Pharmacy?

Infrastructure Expansion Underway

Concurrent with its operational growth, Redcare is executing substantial infrastructure investments. The company has brought a new logistics center in Pilsen online, with capacity to handle 15 million orders annually. In Sevenum, an automation initiative is progressing that aims to double processing capacity while reducing per-order costs by 70%.

Despite these significant capital expenditures, the company maintains its 2025 guidance, projecting an EBITDA margin between 2.0% and 2.5%. The third-quarter margin reached 2.4%, indicating that current expansion remains profitable.

Market Disconnect Presents Opportunity

Redcare shares currently trade near their 52-week low, creating a stark contrast with the company’s robust operational performance. The stock has declined more than 50% since the beginning of the year, potentially creating an opportunity for investors if the new CFO can restore market confidence.

The German electronic prescription market represents a €55 billion opportunity that remains only 1-2% digitized. This contrasts with over-the-counter products, where online penetration has reached 23-25%. With such substantial growth runway available, Redcare’s success may hinge on convincing investors of its long-term potential under its new financial leadership.